CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cotiza a 301.86 USD y tiene una capitalización bursátil de $14.4B. En los últimos 12 meses ha facturado $4.0B con un margen de flujo de caja libre del 12.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by resear…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $3.02 | $2.06 | $2.39 |
| Estimado | $2.97 | $2.74 | $1.95 | $2.35 |
| Sorpresa | — | +10.2% | +5.6% | +1.7% |
| Métrica | CRL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 0.6% | -38.6% | +39.3% |
| Net Margin | -3.6% | -33.6% | +30.0% |
| FCF Margin | 12.9% | -13.9% | +26.8% |
| ROE | -4.6% | -40.4% | +35.8% |
| ROA | -2.0% | -32.0% | +30.0% |
| Current Ratio | 1.29 | 2.84 | -1.55 |
| Debt / Equity | 0.68 | 0.28 | +0.40 |